Brooke Clarke
Public Communications Contact chez SYNAIRGEN PLC
Profil
Brooke Clarke is currently the Senior Vice President & Head-Communications at Synairgen Plc since 2021.
Prior to this, she worked as the Global Head-Communications & Corporate Affairs at Hikma Pharmaceuticals Plc from 2016 to 2021 and as the Senior Director-Global Corporate Communications at Shire Plc from 2011 to 2016.
Ms. Clarke has a graduate degree from the University of London and an undergraduate degree from the University of Michigan.
Postes actifs de Brooke Clarke
| Sociétés | Poste | Début |
|---|---|---|
| SYNAIRGEN PLC | Public Communications Contact | 01/09/2021 |
Anciens postes connus de Brooke Clarke
| Sociétés | Poste | Fin |
|---|---|---|
| HIKMA PHARMACEUTICALS PLC | Public Communications Contact | 01/02/2021 |
| SHIRE | Public Communications Contact | 01/09/2016 |
Formation de Brooke Clarke
| University of Michigan | Undergraduate Degree |
| University of London | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SYNAIRGEN PLC | Health Technology |
| HIKMA PHARMACEUTICALS PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
